The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)
The objectives of the Early Detection Research Network (EDRN; edrn.cancer.gov) are to discover, develop and validate biomarkers and imaging methods to detect early stage cancers and to translate these into clinical tests. The EDRN provides an infrastructure that is essential for this process and has successfully completed more than10 multicenter validation studies. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 18, 2022 Category: Research Source Type: funding
Limited Competition: Cancer Immune Monitoring and Analysis Centers (CIMACs) and Cancer Immunologic Data Center (CIDC) (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-22-038 from the NIH Guide for Grants and Contracts. Through this limited competition Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications to continue support for the Cancer Immune Monitoring and Analysis Centers Cancer Immunologic Data Center (CIMAC-CIDC) Network. The CIMAC-CIDC is a network of laboratories (CIMACs) and a bioinformatics center (CIDC) established to perform correlative studies using biospecimens from cancer immunotherapy clinical trials. Applying a comprehensive set of state-of-the-art immunoprofiling assays and bioinformatics pipelin...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 15, 2022 Category: Research Source Type: funding
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
Funding Opportunity PAR-22-216 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative studies associated with clinical trials; novel cancer therapeutic, symptom/toxicity, and preventive agent development, radiotherapy development activities, and mechanism-driven combinations; and innovative preclinical studies--including the use of new clinically-relevant models and imaging technologies--which could lead to first-in-human clinical tr...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 14, 2022 Category: Research Source Type: funding
Notice of Correction for NOT-CA-22-014 "Notice of Special Interest (NOSI): Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment"
Notice NOT-CA-22-102 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 7, 2022 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food, and Nutrition Insecurity
Notice of Special Interest for research on interventions that address nutrition security and the mechanisms of food insecurity on a variety of health outcomes. Priority populations include racial/ethnic minority populations, lower income populations, and rural and remote populations including tribal communities and insular areas. Geographic coverage: Nationwide -- National Cancer Institute, National Institute on Minority Health and Health Disparities, National Institutes of Health (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - July 6, 2022 Category: American Health Source Type: funding
Notice of Change to PAR-21-341, Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
Notice NOT-CA-22-105 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 5, 2022 Category: Research Source Type: funding
Pre-Application Webinar for NCI's Technologies and Informatics Tools for Cancer Metabolomics NOSI (NOT-CA-22-083)
Notice NOT-CA-22-095 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 1, 2022 Category: Research Source Type: funding
Texas Cancer Screening and Early Detection
Funding for the delivery of evidence-based clinical services to screen for cancer and precancer in underserved populations who do not have adequate access to screening, early detection interventions, and healthcare. Rural and/or medically underserved populations must be included in the defined service area of proposed projects. Geographic coverage: Texas -- Cancer Prevention and Research Institute of Texas (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - June 29, 2022 Category: American Health Source Type: funding
Texas Primary Prevention of Cancer
Funding to implement evidence-based strategies to ensure that all Texans benefit from cancer prevention knowledge. Projects will include interventions to reduce cancer risk, disease burden, and cancer disparities and address social determinants that contribute to cancer burden and disparities. Applications must include the delivery of interventions to non-metropolitan (rural) and/or medically underserved counties in the state. Geographic coverage: Texas -- Cancer Prevention and Research Institute of Texas (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - June 24, 2022 Category: American Health Source Type: funding
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
Funding Opportunity PAR-22-174 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual c...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 23, 2022 Category: Research Source Type: funding
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
Funding Opportunity PAR-22-173 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual c...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 23, 2022 Category: Research Source Type: funding
Notice to Extend Expiration Date for PAR-20-276: Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
Notice NOT-CA-22-092 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 21, 2022 Category: Research Source Type: funding
Notice to Extend Expiration Date for PAR-20-277: Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trial Not Allowed)
Notice NOT-CA-22-093 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 17, 2022 Category: Research Source Type: funding
Notice of Correction to RFA-CA-22-022, "Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)"
Notice NOT-CA-22-090 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 15, 2022 Category: Research Source Type: funding
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional)
Funding Opportunity PAR-22-199 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) will solicit R01 research projects that seek to investigate actionable synthetic vulnerabilities that can be conditionally paired with tumor responses to radiation therapy. The goal of the Precision Approaches in Radiation Synthetic Combinations (PAIRS) program is to develop radiation-synthetic combination strategies and facilitate their adoption into the precision medicine toolkit toward building new and effective anticancer treatments. (Source: NIH Funding...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2022 Category: Research Source Type: funding
